BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,848,449 | -24.6% | 63,038 | -25.1% | 0.01% | -16.7% |
| Q2 2023 | $9,085,439 | -14.2% | 84,179 | -1.0% | 0.01% | -14.3% |
| Q1 2023 | $10,592,562 | -67.3% | 85,033 | -60.6% | 0.01% | -73.1% |
| Q4 2022 | $32,396,444 | -4.4% | 215,660 | -14.2% | 0.03% | +8.3% |
| Q3 2022 | $33,884,000 | -37.8% | 251,228 | -31.2% | 0.02% | -41.5% |
| Q2 2022 | $54,454,000 | -38.3% | 365,214 | -29.4% | 0.04% | -24.1% |
| Q1 2022 | $88,225,000 | -48.8% | 517,269 | -22.6% | 0.05% | -41.3% |
| Q4 2021 | $172,268,000 | +12.6% | 668,224 | +19.2% | 0.09% | +2.2% |
| Q3 2021 | $153,028,000 | +18.6% | 560,557 | -2.7% | 0.09% | +16.9% |
| Q2 2021 | $129,007,000 | +156.8% | 576,232 | +25.3% | 0.08% | +140.6% |
| Q1 2021 | $50,227,000 | -22.4% | 459,987 | -42.0% | 0.03% | -17.9% |
| Q4 2020 | $64,689,000 | +26966.5% | 793,541 | +22881.2% | 0.04% | – |
| Q3 2020 | $239,000 | +25.1% | 3,453 | +20.6% | 0.00% | – |
| Q2 2020 | $191,000 | – | 2,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |